Form 4 for CNMD CONMED Corp
Accepted 2024-09-09 00:00:00 ET · period of report 2024-09-05 · accession 0001127602-24-023639 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-09-09 | 2024-09-05 | CNMD | Farkas Charles | Dir | F - Tax | $74.31 | -534 | 20.3K | -3% | -$39.7K |
| D | 2024-09-09 | 2024-09-05 | CNMD | Farkas Charles | Dir | M - OptEx | $39.64 | +1,000 | 20.9K | +5% | +$39.6K |
| D | 2024-09-09 | 2024-09-05 | CNMD | Farkas Charles | Dir | M - OptEx | $0.00 | -1,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-05 | F | D | 534 | $74.31 | 20,346 | D | — | — | |
| 2 | Common | Common Stock | 2024-09-05 | M | A | 1,000 | $39.64 | 20,880 | D | — | — | |
| 3 | Derivative | SARs (Stock Appreciation Rights) | 2024-09-05 | M | D | 1,000 | $0.00 | 0 | D | $39.64 · 2015-06-01 to 2024-09-11 | 1,000 Common Stock | (F1) The stock appreciation rights ("SARs") were granted under the Company's 2007 Amended and Restated Non-Employee Director Equity Compensation Plan, with the SARs vesting on June 1, 2015 and expiring on September 11, 2024. |